Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$133,036
-$12,048 QoQ
Shares Held
1,053
+1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,960
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TFC Financial Management, Inc. holds $19,845,722 across 13 Drug Manufacturers - General names. GILD ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
48,938 | $12,428,783 | |
| 2 | MRK |
Merck & Co., Inc.
|
38,730 | $4,976,805 | |
| 3 | LLY |
ELI LILLY & Co
|
877 | $1,051,900 | |
| 4 | ABBV |
AbbVie Inc.
|
3,399 | $855,324 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
1,053 | $133,036 | |
| 6 | NVS |
Novartis AG
|
576 | $90,270 | |
| 7 | NVO |
Novo Nordisk A S
|
1,619 | $77,614 | |
| 8 | AMGN |
Amgen Inc
|
200 | $72,424 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,036 | 1,053 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $145,084 | 1,041 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $127,772 | 1,041 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $86,691 | 781 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $86,589 | 781 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $86,838 | 775 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $136,892 | 1,482 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $126,179 | 1,505 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $102,160 | 1,489 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $110,534 | 1,509 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $121,758 | 1,503 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $111,210 | 1,484 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $115,682 | 1,501 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $123,542 | 1,489 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $126,285 | 1,471 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $90,745 | 1,471 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $90,922 | 1,471 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $173,831 | 2,924 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $212,311 | 2,924 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $203,822 | 2,918 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,446 | 21 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,357 | 21 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,223 | 21 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,285 | 52 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||